Cargando…

TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells

BACKGROUND: Phosphatidylcholine (PC) is a major lipid of the gastrointestinal mucus layer. We recently showed that mucus from patients suffering from ulcerative colitis has low levels of PC. Clinical studies reveal that the therapeutic addition of PC to the colonic mucus using slow release preparati...

Descripción completa

Detalles Bibliográficos
Autores principales: Treede, Irina, Braun, Annika, Jeliaskova, Petia, Giese, Thomas, Füllekrug, Joachim, Griffiths, Gareth, Stremmel, Wolfgang, Ehehalt, Robert
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714528/
https://www.ncbi.nlm.nih.gov/pubmed/19594939
http://dx.doi.org/10.1186/1471-230X-9-53
_version_ 1782169685471526912
author Treede, Irina
Braun, Annika
Jeliaskova, Petia
Giese, Thomas
Füllekrug, Joachim
Griffiths, Gareth
Stremmel, Wolfgang
Ehehalt, Robert
author_facet Treede, Irina
Braun, Annika
Jeliaskova, Petia
Giese, Thomas
Füllekrug, Joachim
Griffiths, Gareth
Stremmel, Wolfgang
Ehehalt, Robert
author_sort Treede, Irina
collection PubMed
description BACKGROUND: Phosphatidylcholine (PC) is a major lipid of the gastrointestinal mucus layer. We recently showed that mucus from patients suffering from ulcerative colitis has low levels of PC. Clinical studies reveal that the therapeutic addition of PC to the colonic mucus using slow release preparations is beneficial. The positive role of PC in this disease is still unclear; however, we have recently shown that PC has an intrinsic anti-inflammatory property. It could be demonstrated that the exogenous application of PC inhibits membrane-dependent actin assembly and TNF-α-induced nuclear NF-κB activation. We investigate here in more detail the hypothesis that the exogenous application of PC has anti-inflammatory properties. METHODS: PC species with different fatty acid side chains were applied to differentiated and non-differentiated Caco-2 cells treated with TNF-α to induce a pro-inflammatory response. We analysed TNF-α-induced NF-κB-activation via the transient expression of a NF-κB-luciferase reporter system. Pro-inflammatory gene transcription was detected with the help of a quantitative real time (RT)-PCR analysis. We assessed the binding of TNF-α to its receptor by FACS and analysed lipid rafts by isolating detergent resistant membranes (DRMs). RESULTS: The exogenous addition of all PC species tested significantly inhibited TNF-α-induced pro-inflammatory signalling. The expression levels of IL-8, ICAM-1, IP-10, MCP-1, TNF-α and MMP-1 were significantly reduced after PC pre-treatment for at least two hours. The effect was comparable to the inhibition of NF-kB by the NF-kB inhibitor SN 50 and was not due to a reduced binding of TNF-α to its receptor or a decreased surface expression of TNF-α receptors. PC was also effective when applied to the apical side of polarised Caco-2 cultures if cells were stimulated from the basolateral side. PC treatment changed the compartmentation of the TNF-α-receptors 1 and 2 to DRMs. CONCLUSION: PC induces a prolonged inhibition of TNF-α-induced pro-inflammatory signalling. This inhibition may be caused by a shift of the TNF-α receptors at the surface to lipid rafts. Our results may offer a potential molecular explanation for the positive role of PC seen in clinical studies for the treatment of ulcerative colitis.
format Text
id pubmed-2714528
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27145282009-07-24 TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells Treede, Irina Braun, Annika Jeliaskova, Petia Giese, Thomas Füllekrug, Joachim Griffiths, Gareth Stremmel, Wolfgang Ehehalt, Robert BMC Gastroenterol Research Article BACKGROUND: Phosphatidylcholine (PC) is a major lipid of the gastrointestinal mucus layer. We recently showed that mucus from patients suffering from ulcerative colitis has low levels of PC. Clinical studies reveal that the therapeutic addition of PC to the colonic mucus using slow release preparations is beneficial. The positive role of PC in this disease is still unclear; however, we have recently shown that PC has an intrinsic anti-inflammatory property. It could be demonstrated that the exogenous application of PC inhibits membrane-dependent actin assembly and TNF-α-induced nuclear NF-κB activation. We investigate here in more detail the hypothesis that the exogenous application of PC has anti-inflammatory properties. METHODS: PC species with different fatty acid side chains were applied to differentiated and non-differentiated Caco-2 cells treated with TNF-α to induce a pro-inflammatory response. We analysed TNF-α-induced NF-κB-activation via the transient expression of a NF-κB-luciferase reporter system. Pro-inflammatory gene transcription was detected with the help of a quantitative real time (RT)-PCR analysis. We assessed the binding of TNF-α to its receptor by FACS and analysed lipid rafts by isolating detergent resistant membranes (DRMs). RESULTS: The exogenous addition of all PC species tested significantly inhibited TNF-α-induced pro-inflammatory signalling. The expression levels of IL-8, ICAM-1, IP-10, MCP-1, TNF-α and MMP-1 were significantly reduced after PC pre-treatment for at least two hours. The effect was comparable to the inhibition of NF-kB by the NF-kB inhibitor SN 50 and was not due to a reduced binding of TNF-α to its receptor or a decreased surface expression of TNF-α receptors. PC was also effective when applied to the apical side of polarised Caco-2 cultures if cells were stimulated from the basolateral side. PC treatment changed the compartmentation of the TNF-α-receptors 1 and 2 to DRMs. CONCLUSION: PC induces a prolonged inhibition of TNF-α-induced pro-inflammatory signalling. This inhibition may be caused by a shift of the TNF-α receptors at the surface to lipid rafts. Our results may offer a potential molecular explanation for the positive role of PC seen in clinical studies for the treatment of ulcerative colitis. BioMed Central 2009-07-13 /pmc/articles/PMC2714528/ /pubmed/19594939 http://dx.doi.org/10.1186/1471-230X-9-53 Text en Copyright ©2009 Treede et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Treede, Irina
Braun, Annika
Jeliaskova, Petia
Giese, Thomas
Füllekrug, Joachim
Griffiths, Gareth
Stremmel, Wolfgang
Ehehalt, Robert
TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells
title TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells
title_full TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells
title_fullStr TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells
title_full_unstemmed TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells
title_short TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells
title_sort tnf-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714528/
https://www.ncbi.nlm.nih.gov/pubmed/19594939
http://dx.doi.org/10.1186/1471-230X-9-53
work_keys_str_mv AT treedeirina tnfainducedupregulationofproinflammatorycytokinesisreducedbyphosphatidylcholineinintestinalepithelialcells
AT braunannika tnfainducedupregulationofproinflammatorycytokinesisreducedbyphosphatidylcholineinintestinalepithelialcells
AT jeliaskovapetia tnfainducedupregulationofproinflammatorycytokinesisreducedbyphosphatidylcholineinintestinalepithelialcells
AT giesethomas tnfainducedupregulationofproinflammatorycytokinesisreducedbyphosphatidylcholineinintestinalepithelialcells
AT fullekrugjoachim tnfainducedupregulationofproinflammatorycytokinesisreducedbyphosphatidylcholineinintestinalepithelialcells
AT griffithsgareth tnfainducedupregulationofproinflammatorycytokinesisreducedbyphosphatidylcholineinintestinalepithelialcells
AT stremmelwolfgang tnfainducedupregulationofproinflammatorycytokinesisreducedbyphosphatidylcholineinintestinalepithelialcells
AT ehehaltrobert tnfainducedupregulationofproinflammatorycytokinesisreducedbyphosphatidylcholineinintestinalepithelialcells